[1] Cheviot L, Fiore E, Vitter P, et al.  Outcome of thyroid function in Graves'patients treated with radioiodine: role of thyroid-stimulating and thyrotrophic-blocking antibodies and of radioiodine-induced thyroid damage[J]. J Clin Endocrinol Metab, 1998, 83(1): 40-46.
[2] Van Dyk HJ.  Orbital Graves'diseases[J]. A modification of the"NO SPECS"classication. Ophthalmology, 1981, 88(6): 479-483.
[3] Hamilton HE, Schultz RO, De Gowin EL.  The endocrine eye lesion in hyperthyroidism[J]. Its incidence and course in 165 patients treated for thyrotoxicosis with iodine. Arch Intern Med, 1960, 105: 675-685.
[4] Werner SC, Coelho B, Ouimby EH.  Ten year results of I-131 therapy in hyperthyroidism[J]. Bull N Y Acad Med, 1957, 33(11): 783-806.
[5] Bartalena L, Martino E, Marcocci C, et al.  More on smoking habits and Graves'ophthalmopathy[J]. J Endocrinol Invest, 1989, 12(10): 733-737.   doi: 10.1007/BF03350047
[6] Tellez M, Cooper J, Edmonds C.  Graves'ophthalmopathy in relation to cigarette smoking and ethnic origin[J]. Clin Endocrinal(Oxf), 1992, 36(3): 291-294.   doi: 10.1111/j.1365-2265.1992.tb01445.x
[7] Bonnema SJ, Bartalena L, Toft AD, et al.  Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres[J]. Eur J Endocrinol, 2002, 147(1): 1-11.
[8] 段炼, 李险峰, 陆克义, 等.  99Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的临床应用[J]. 中华眼科杂志, 2006, 42(12): 1068-1072.   doi: 10.3760/j:issn:0412-4081.2006.12.004
[9] Acharya SH, Avenell A, Philip S, et al.  Radioiodine therapy(RAI)for Graves'disease(GD)and the effect on ophthalmopathy: a systematic review[J]. Clin Endocrinol(Oxf), 2008, 69(6): 943-950.   doi: 10.1111/j.1365-2265.2008.03279.x